Bristol Myers Squibb and Cellares reach $380 million supply deal for CAR-T therapies

(Reuters) – Bristol Myers Squibb and Cellares said on Monday they have reached a $380 million deal to supply CAR-T cell therapies to more patients.

(Reporting by Christy Santhosh; Editing by Shinjini Ganguli)